American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

  • About
    • Mission Statement and Purpose
    • Divisions & Services of the Society
      • Education
        • Scientific Program/Resident Courses
        • Surgical Videos
        • Journal Club
        • Journals
        • Global Outreach
        • Awards
          • Margaret F. Butler Award
      • Diversity, Equity and Inclusion Division
      • Patient Care
        • Cancer Survivorship
          • Patient Education on Post-Treatment Care
          • Interviews with Cancer Survivors
        • Cancer Prevention
          • SLIDE DECK: HPV-Related Oropharyngeal Cancer
        • Guidelines/Position Statements
        • Find-A-Physician
      • Research
        • Grant Information
        • Clinical Trial
        • Tissue Banks
      • Administrative Division
        • AHNS Process for Evaluating Projects Requiring Funding
    • Leadership
    • History
      • Society Background
      • AHNS History Interviews
      • Past Presidents
      • In Memory
    • AHNS Newsletter
    • Professionalism & Ethics
    • AHNS Policies and Procedures (P&P) Manual
    • AHNS Foundation
    • AHNS Bylaws
    • AHNS Staff
    • AHNS News and Announcements
    • COVID-19 Bulletin Board
  • Heads Up!
  • Post a Job
  • Meetings
    • AHNS Virtual Education Series
      • TORS Webinar Series
    • AHNS Meetings Info
    • AHNS Call For Abstracts
    • Past Meetings
    • Related Meetings
  • For Patients
  • For Trainees
    • Fellowship Curriculum for FY2024-2025
      • For Current AHNS Fellows
      • Certificate of Completion Request
    • Accredited Fellowships
      • Directory of Fellowships
      • AHNS Fellowship Match
      • Fellowship Curriculum
      • Fellowship Graduates
      • For Program Directors
    • AHNS Surgical Videos
    • Fellows’ Virtual Tumor Boards
    • Cutaneous Cancer
  • Sections
    • Endocrine Surgery
    • Skull Base Surgery Section
    • Reconstructive Head & Neck Surgery
      • Head and Neck Reconstruction- Information for Patients
    • Mucosal Malignancy Section
      • Mucosal Malignancy Section Patient Information
    • Salivary Gland Section
      • Salivary Gland Section Patient Education Handout: Parotidectomy
    • Cutaneous Cancer
  • Find-A-Physician
  • Member Central
    • Join AHNS
    • Find-A-Physician
    • Mailing List Order
  • Login
    • Password Reset
  • Donate

Published on January 25, 2023 by AHNS Webmaster

Margaret F. Butler Outstanding Mentor of Women in Head and Neck Surgery Award

The American Head and Neck Society and the Women in Head and Neck Surgery Service are soliciting nominations for the Margaret F. Butler Outstanding Mentor of Women in Head and Neck Surgery Award.

Dr. Margaret Butler was the first female otolaryngology chair in the United States. In 1906, she was appointed Chair of Ear, Nose and Throat at Women’s Medical College of Pennsylvania. As a respected otolaryngologist and an ambassador of the specialty, Dr. Butler provided a blueprint for generations of future female otolaryngologists. The purpose of this Award is to recognize individuals who have demonstrated leadership in promoting gender diversity in the field of Head and Neck Surgery and its related endeavors. A secondary goal is to encourage the training and mentorship of future women leaders in our specialty.

Individuals nominated for this award will have the following qualities:

1. Has demonstrated leadership and a consistent track record of promoting gender diversity and equity in head and neck surgery, and its related fields.

2. Has consistently supported and promoted women in head and neck surgery and its related endeavors, as well as mentoring individuals through merit-based career advancements and promotions.

3. Has measurable impact in the promotion of women in head and neck surgery and its related fields, i.e. career advancement of mentees, mentorship in publications and research, etc.

4. Present or past member of the AHNS is preferred but not required.

Submission requires a nomination letter with a second supporting letter from an AHNS member and the nominee’s CV/Resume, to be uploaded with the application.

Nominations will be accepted until February 10, 2023, at 5:00 PM EST. Only one application will be accepted per nominee.

The winner will be honored at the Women in Head and Neck Surgery Reception at the AHNS International Conference in Montreal, July 8-12, 2023 and receive $1,500 towards conference registration and travel.

Previous Award Winners
2019 – Marion Couch, MD, PhD, MBA
2020 – Cherie-Ann Nathan, MD, FACS
2021 – Lisa Orloff, MD, FACS
2022 – Amy Y. Chen, MD, MPH, FACS

Thank you for your submissions!

Amy Anne Lassig, MD, MS and Karen Y. Choi, MD

Co-Chairs, Margaret F. Butler Outstanding Mentor of Women in Head and Neck Surgery Award

Published on January 23, 2023 by AHNS Webmaster

Have you Read the Recent Study in NEJM about Neoadjuvant Cemiplimab in Advanced Resectable Cutaneous SCC from Dr. Neil Gross Et Al??

Check out this infographic summary.

Thanks to contributors Dr. Rebecca Hammon and Dr. Ashok Jethwa

Read More Here

Published on January 23, 2023 by Mark Wax

Reconstruction of the parotid bed following resection for metastatic skin cancer

blog article from the ASN Cutaneous Cancer Section

When large metastases are present in the parotid bed, surgical excision is the preferred modality of treatment.  Depending on the extent of the disease, either a classic superficial parotidectomy or a near total parotidectomy with excision of the deep lobe may be required for complete clearance of the nodal tissue. A comprehensive or limited neck dissection may also be concurrently performed.

This resection of the parotid gland can lead to significant concavity deformities (Figure 1).

Figure 1: This young woman demonstrates the concavity defect from a parotidectomy

Historically, the volume defect had not been reconstructed.  Over time, the soft tissue defect may have less abrupt edges and soften, but the concavity will always be present. The concavity imparts no functional deficits but may result in cosmetic dissatisfaction. In the setting of malignancy, the cosmetic deformity is often considered by most surgeons to be a minor issue in the post-operative period as concern for facial nerve function predominates.

Patients, however, can have differing opinions on the cosmetic outcome of an extensive parotidectomy with concavity deformity1. Ciuman et al demonstrated that parotidectomy for benign disease did not impact overall quality of life, but cosmetic discontent with the facial contour deformity was quite high with 70% reporting a change in appearance.2 Greater than half reported noticeable depression as a result of the cosmetic deformity. Casual observers were also able to notice the contour defect. A review of 274 patients by Bianchi et al discovered that the most essential factor impacting aesthetic outcome was the amount of parotid tissue removal.3 However, the full impact of the contour defect on patient’s quality of life has not been fully elucidated due to the lack of symptom specific questions on quality-of-life instruments1.

Minimal parotidectomy with neck dissection may yield smaller volume defects and spare involvement of the overlying cutaneous tissue. Surgical reconstruction of the facial skin in this situation is not required and the volume defect may be addressed with a range of reconstructive options. The reconstructive paradigm to address soft tissue defects ranges from sternocleidomastoid (SCM) muscle flaps, acellular dermal implants, superficial musculoaponeurotic system (SMAS) plication, fat graft, and free tissue transfer.4,5 Both the SMAS plication and SCM muscle flap have been shown to be equivalent to soft tissue fillers and result in improved patient satisfaction with their final appearance4. Acellular dermal implants like Alloderm and fat grafting are ideal for smaller volume parotid defects (Figure 2).

a) A small superficial parotidectomy defect that will create a divot in the cheek is present.
b) The defect has been reconstructed with layered AlloDerm to provide adequate cosmesis

Reconstructive options are primarily volume-driven and often imparts no alterations in overall functional status.  It is our preference to consider reconstruction in the majority of parotidectomy defects.  Small contour defects are easily reconstructed by the ablative team at the time of the initial surgery.  Larger defects are approached and a 2-team fashion with involvement of our facial plastics colleagues.  When malignancy surveillance is required, it is often done with radiologic imaging so the reconstructive modality used does not impact surveillance or outcome.  All reconstructive tissues will atrophy or shrink over time.  if adjuvant radiation is expected; fat grafting may atrophy significantly.  In our experience it is rare to have patients unhappy with too much bulk in the reconstruction.  As with most fat grafting and other parts of the head and neck up to 50% greater volume should be utilized depending on what the next course of treatment is.  When there is cutaneous involvement and the defect is not extensive, cervicofacial advancement flaps are ideal for functional and cosmetic reconstruction.

Soft tissue defects greater than 70 cm3 are more common in the setting of advanced metastatic skin cancer to the parotid bed since extensive parotidectomy with concurrent neck dissection is usually necessary, and local constructive modalities are not adequate in these situations.6 There is an increased risk of facial skin involvement with aggressive disease, resulting in another layer of complexity in the reconstruction. Scenarios where local tissue may not be ideal include the large size of the defect, previous rotational flaps disrupting the facial skin or soft tissue blood supply, prior radiation history, heavy smoker, or poor prognostic indicators for wound healing. When defects are of a more significant nature or the wound bed is a more hostile environment, then regional or free tissue transfer should be considered (Figure 3 a,b).5

a) This gentleman had a parotidectomy neck dissection with a small skin defect.
b) A supraclavicular flap was utilized for reconstruction of the soft tissue and skin.

Utilization of free tissue transfer for parotid skin defects are relatively rare. When necessary, the ideal flap would provide not only coverage of the skin defect, but also would reconstruct the soft tissue defect from parotidectomy and neck dissection. Radial forearm free flaps and anterolateral thigh flaps are most commonly used.  The lateral arm flap has recently been proposed in the literature as another alternative option. The ultimate decision depends on the volume of tissue required and patient body habitus (Figure 4a,b,c).4

a) This gentleman had a skin cancer metastatic to the parotid region requiring skin resection parotidectomy and neck dissection.
b) An anterolateral thigh free flap was utilized to reconstruct the soft tissue as well as the skin defect.
c) At 1 year facial contour remains good

Patients seem to anecdotally report favorable outcomes after free tissue transfer. Cannady et al described a series of 18 patients with free tissue transfer for soft tissue volume reconstruction of total parotidectomy defects with acceptably cosmetic outcomes reported by patients.5 The benefits of free tissue transfer include healthy vascularized tissue in the wound bed, especially if adjunct radiation therapy is to be pursued post-operatively, adequate skin paddle for facial skin defects with no local tissue available for rotation, and adipose or muscular tissue to address the soft tissue volume loss. Unlike a fat graft, vascularized adipose tissue is less likely to atrophy to the same extent.

In terms of free tissue transfer, radial forearm flap, anterolateral thigh flap, and lateral arm flap are acceptable options when both a skin and soft tissue defect needs to be addressed. When there is no facial skin defect, an adipose fascial free flap from the thigh that results in minimal donor site morbidity may be a more suitable reconstructive modality. Described by Fritz et al, this flap can be harvested as a 2-team approach with a straightforward inset and vascular anastomosis adding an hour or two to the overall length of the surgery.7 Even though vascularized adipose tissue does not shrink like fat grafts, there is a possibility that these grafts will also atrophy to a considerable extent like other free tissue transfers.8 Long-term data is lacking, but there may be a role in overcorrection of the soft tissue volume loss at the time of reconstruction in anticipation of volume loss, especially in the setting of post-operative radiation therapy.

Reconstruction of the parotid bed volume loss may not be like other typical head and neck reconstructions since there is no functional role.  Anecdotal evidence from patients report poor cosmetic outcomes and overall dissatisfaction with contour deformities with this defect. There is very little quantitative evidence in the literature regarding its impact on the overall quality of life, but there may still be a role for parotid bed reconstruction to obtain good cosmetic outcomes. Reconstructive options are relatively straightforward and should be considered during pre-operative evaluation.  Patient morbidity from reconstruction is relatively minor.  The benefits are potentially major.

Mark K Wax MD FACS FRCS(C) 1
Professor Otolaryngology-HNS
Professor Maxillo Facial Surgery
Program Director

Sara Yang MD1
Fellow Microvascular and Reconstructive Surgery
Oregon Health Sciences University

References

  • Nitzan D, Kronenberg J, Horowitz Z, Wolf M, Bedrin L, Chaushu G, Talmi YP: Quality of life following parotidectomy for malignant and benign disease. Plast Reconstr Surg. 2004 Oct;114(5):1060-7
  • Ciuman RR, Oels W, Jaussi R, Dost P: Outcome, general, and symptom-specific quality of life after various types of parotid resection. Laryngoscope 2012 Jun;122(6):1254-61
  • Bianchi B, Ferri A, Ferrari S, Copelli C, Sesenna E: Improving esthetic results in benign parotid surgery: statistical evaluation of facelift approach, sternocleidomastoid flap, and superficial musculoaponeurotic system flap application. J Oral Maxillofac Surg 2011 Apr;69(4):1235-41
  • Militsakh ON, Sanderson JA, Lin D, Wax MK: Rehabilitation of a parotidectomy patient–a systematic approach. Head Neck 2013 Sep;35(9):1349-61
  • Cannady SB, Seth R, Fritz MA, Alam DS, Wax MK: Total parotidectomy defect reconstruction using the buried free flap. Otolaryngol Head Neck Surg 2010 Nov;143(5):637-43
  • Tamplen M, Knott PD, Fritz MA, Seth R. Controversies in Parotid Defect Reconstruction. Facial Plast Surg Clin North Am. 2016 Aug;24(3):235-43. doi: 10.1016/j.fsc.2016.03.002. Epub 2016 May 24. PMID: 27400838.
  • Ciolek PJ, Prendes BL, Fritz MA. Comprehensive approach to reestablishing form and function after radical parotidectomy. Am J Otolaryngol. 2018 Sep-Oct;39(5):542-547. doi: 10.1016/j.amjoto.2018.06.008. Epub 2018 Jun 7. PMID: 29907429.
  • Dennis SK, Masheeb Z, Abouyared M. Free flap volume changes: can we predict ideal flap size and future volume loss? Curr Opin Otolaryngol Head Neck Surg. 2022 Oct 1;30(5):375-379. doi: 10.1097/MOO.0000000000000832. Epub 2022 Jul 18. PMID: 36036533.

Published on January 20, 2023 by AHNS Webmaster

US vs HPV Prevention Week Free Webinar Series

AHNS members,

Please take a moment to distribute information on the upcoming US vs. HPV Prevention Week to your patients and colleagues. This joint initiative between the Global Initiative Against HPV and Cervical Cancer (GIAHC), American Medical Women’s Association (AMWA) and Indiana University National Center of Excellence in Women’s Health will take place next week from January 23- January 27, 2023. This FREE event will include a session on Thursday, January 26th from 12-1PM EST entitled “HPV Oropharynx Cancer: What You Need to Know in 2023” and will include presentations from several AHNS members.

Register here to register for the FREE live or recorded webinars. These webinars are designed to reach a broad audience, including oncologists treating HPV-related cancers, primary care physicians, allied health professionals, and patients. Please join us in fighting against HPV-related cancers.

The full agenda can be accessed here and additional background information can be accessed here. The agenda for Thursday’s session is included below.

Sincerely,
AHNS Cancer Prevention Service

January 26th, 12-1PM EST
HPV Oropharynx Cancer: What You Need to Know in 2023

Moderator:
Cecelia E. Schmalbach, MD, MSc, FACS
David Myers, MD Professor and Chair
Department of Otolaryngology-Head & Neck Surgery
Director, Temple Head and Neck Institute
Lewis Katz School of Medicine at Temple University

HPV Head & Neck Cancer: 2023 Update
Gina D. Jefferson, MD, MS, FACS
Professor of Otolaryngology-HNS
Vice Chair of Education; Division Chief, Head & Neck Surgery
The University of Mississippi Medical Center

HPV Induced Oropharyngeal Cancer: What to Look For & How to Treat
Anthony Morlandt, MD, DDS, FACS
Professor & Chief, Oral Oncology
Director, Head & Neck Oncology Fellowship
Dept. of OMS, Univ. of Alabama at Birmingham

The Patient’s Journey
Alice C. Lin, MD, FACS
Head & Neck Surgery, Dept. of Otolaryngology
Kaiser Permanente
Los Angeles, CA

Jacqueline Sol
Patient

Live Question/Answer Session

REGISTER NOW

Published on January 19, 2023 by AHNS Webmaster

Apply Now for the 2023 AHNS Community Service Awards

The American Head and Neck Society’s Cancer Prevention Service is pleased to offer the 2023 Cancer Prevention Community Service Awards. These awards support projects or community activities related to oral head and neck cancer awareness and prevention. Each award, in the amount of $1,000.00, will be given to an individual, department, organization, or institution in support of a patient or community-oriented project held in conjunction with Oral Head & Neck Cancer Awareness Week (OHANCAW), the annual awareness & prevention event presented by our colleagues at the Head & Neck Cancer Alliance. The 2023 OHANCAW takes place April 16-22, 2023.

A total of five (5) awards are granted – four (4) AHNS Community Service Awards and an international award funded by the Head and Neck Cancer Alliance – the HNCA/AHNS International Outreach Cancer Prevention Award.

Applicants must submit a letter, not to exceed 2 typed pages, containing a detailed description of the project and including the following:

  • The targeted population;
  • The methods to be used;
  • The expected outcome;
  • The expected impact on community health and/or on our knowledge and understanding of head and neck cancer prevention and early detection;
  • The estimated/actual cost, of the project;
  • Any other available funding the project has or will receive.
  • We are looking for unique, innovative projects for this award.

APPLICATION & INFORMATION

Applications are due Monday, February 20th at midnight Eastern Time. Recipients will be announced in mid March.

Please note that indirect support and salary are not supported as part of this award. Recipients of this award, upon completion of their project, will be requested to submit a brief report describing how the funding was spent, the results of the project and an overall evaluation.

  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 68
  • Next Page »

News and Announcements

  • AHNS YMCP Episode 11 – Melina Windon, MD, Janice Farlow, MD, Eric Gantwerker, MD May 8, 2025
  • Artificial Intelligence in Management of H&N Cancer: New Horizons Presented April 28, 2025
  • A conversation with Dr. Uppaluri: Neoadjuvant Therapy for Advanced H&N Mucosal April 25, 2025
  • The End of April Head and Neck Cancer Awareness Month Approaches! April 23, 2025
  • April is National CBD Awareness Month! April 21, 2025

AHNS Meetings and Events

AHNS 2025 Annual Meeting
Held during the Combined Otolaryngology Spring Meetings (COSM)

May 14-18, 2025
Hyatt Regency New Orleans
New Orleans, Louisiana

learn more...

Contact Us

AHNS, 11300 W. Olympic Blvd, Suite 600
Los Angeles, CA 90064
ph: (310) 437-0559 / fx: (310) 437-0585
[email protected]

Welcome to the AHNS Virtual Repository of Scientific Research

Sections

  • Virtual Repository of Scientific Resources
  • Cell Lines Browse and Search
  • Omics Browse and Search
  • Patient Derived Xenografts Browse and Search
  • Plasmids Browse and Search
  • Pre-Clinical Models Browse and Search
  • Transferable Expertise Browse and Search
  • Transgenic Mice Browse and Search

© 2002–2025 American Head and Neck Society · Privacy and Return Policy
· Managed by BSC Management, Inc